GSK PLC
(BUE:GSK)
ARS
13650
150 (1.11%)
Market Cap: 80.91 Til
Enterprise Value: 98.20 Til
PE Ratio: 16.35
PB Ratio: 4.55
GF Score: 56/100 - Q2 2024 GSK plc Earnings Call TranscriptJul 31, 2024ARS12475 (-1.58%)Earnings
- Q1 2024 GSK plc Earnings Call TranscriptMay 01, 2024ARS11345Earnings
- Q1 2024 GSK plc Earnings Call TranscriptMay 01, 2024ARS11345Earnings
- Q4 2023 GSK plc Earnings Call TranscriptJan 31, 2024ARS12243 (-0.92%)Earnings
- GSK plc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- GSK plc -Getting Ahead of Respiratory Diseases TranscriptNov 30, 2023
- Q3 2023 GSK plc Earnings Call TranscriptNov 01, 2023ARS7619.5 (+0.36%)Earnings
- GSK plc Getting ahead of HIV with ViiV Management Presentation TranscriptSep 28, 2023
- GSK plc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2023
- GSK plc at Citi BioPharma Conference TranscriptSep 07, 2023
- Q2 2023 GSK plc Earnings Call TranscriptJul 26, 2023ARS4855 (+0.32%)Earnings
- GSK plc Virtual Management Event: Getting Ahead of Infectious Disease TranscriptJun 27, 2023
- GSK plc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- GSK plc ESG Investor Education Event TranscriptJun 06, 2023
- Q1 2023 GSK plc Earnings Presentation TranscriptApr 26, 2023
- Q4 2022 GSK plc Earnings Call TranscriptFeb 01, 2023ARS3245 (-0.11%)Earnings
- GSK plc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 GSK plc Earnings Call TranscriptNov 02, 2022ARS2507.5 (-1.12%)Earnings
- GSK plc Investor Science Event TranscriptOct 21, 2022
- GSK plc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 16, 2022
- GSK plc at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 GSK plc Earnings Call TranscriptJul 27, 2022ARS3089Earnings
- GSK plc at Deutsche Bank dbAccess Global Consumer Conference TranscriptJun 14, 2022
- GSK plc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- GSK plc at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Q1 2022 GlaxoSmithKline PLC Earnings Call TranscriptApr 27, 2022ARS2986.88 (+0.65%)Earnings
- GlaxoSmithKline PLC at UBS Global Consumer & Retail Conference (Virtual) TranscriptMar 09, 2022
- GlaxoSmithKline PLC at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- GlaxoSmithKline PLC and HALEON PLC Consumer Healthcare Capital Markets Day TranscriptFeb 28, 2022
- GlaxoSmithKline PLC to Discuss About Investing in Healthcare Innovations: A Case Study of Multi-stakelholder Capitalism in Practice Call TranscriptFeb 10, 2022
- Q4 2021 GlaxoSmithKline PLC Earnings Call TranscriptFeb 09, 2022ARS2956.25 (-2.67%)Earnings
- GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- GlaxoSmithKline PLC at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- GlaxoSmithKline PLC Meet GSK Management: Getting Ahead of HIV TranscriptNov 29, 2021
- GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week TranscriptNov 07, 2021
- Q3 2021 GlaxoSmithKline PLC Earnings Call TranscriptOct 27, 2021ARS2544.38 (+0.77%)Earnings
- GlaxoSmithKline PLC at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 06, 2021
- GlaxoSmithKline PLC at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 GlaxoSmithKline PLC Earnings Call TranscriptJul 28, 2021ARS2245 (+0.84%)Earnings
- Alector Inc to Discuss Collaboration with GlaxoSmithKline PLC for AL001 & AL101 Call TranscriptJul 02, 2021
- GlaxoSmithKline PLC Investor Update TranscriptJun 23, 2021
- Iteos Therapeutics Inc to Discuss Collaboration with GlaxoSmithKline PLC for EOS-448 Call TranscriptJun 14, 2021
- Q1 2021 GlaxoSmithKline PLC Earnings Call TranscriptApr 28, 2021ARS1846.25 (+1.16%)Earnings
- GlaxoSmithKline PLC at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- GlaxoSmithKline PLC at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 GlaxoSmithKline PLC Earnings Call TranscriptFeb 03, 2021ARS1734.38 (-3.65%)Earnings
- GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- GlaxoSmithKline PLC at Goldman Sachs Healthcare CEOs Unscripted Conference (Virtual) TranscriptJan 05, 2021
- GlaxoSmithKline PLC at Morgan Stanley ESG Insights Conference (Virtual) TranscriptDec 09, 2020
- Q3 2020 GlaxoSmithKline PLC Earnings Call TranscriptOct 28, 2020ARS1712.5 (-7.49%)Earnings
- GlaxoSmithKline PLC to Discuss RSV Vaccines Data Investor Call TranscriptOct 22, 2020
- GlaxoSmithKline PLC at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- GlaxoSmithKline PLC at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 GlaxoSmithKline PLC Earnings Call TranscriptJul 29, 2020ARS1487.5 (-0.58%)Earnings
- GlaxoSmithKline PLC Annual Shareholders Meeting TranscriptMay 06, 2020
- Q1 2020 GlaxoSmithKline PLC Earnings Call TranscriptApr 29, 2020ARS1512.5 (-8.33%)Earnings
- Q4 2019 GlaxoSmithKline PLC Earnings Call TranscriptFeb 05, 2020ARS1181.88 (-4.88%)Earnings
- GlaxoSmithKline PLC at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- GlaxoSmithKline PLC to Discuss Pivotal DREAMM-2 Data on Belantamab Mafodotin (GSK'916) Call TranscriptDec 17, 2019
- Q3 2019 GlaxoSmithKline PLC Earnings Call TranscriptOct 30, 2019ARS1096.25 (-2.56%)Earnings
- GlaxoSmithKline PLC to Discuss Data Presented at ESMO TranscriptSep 30, 2019
- GlaxoSmithKline PLC Vaccines Investor Event TranscriptSep 26, 2019
- Q2 2019 GlaxoSmithKline PLC Earnings Call TranscriptJul 24, 2019ARS561.25 (+4.91%)Earnings
- Valneva SE to Announce Agreement with GlaxoSmithKline PLC to End Strategic Alliance Agreement Call TranscriptJun 21, 2019
- GlaxoSmithKline PLC at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Q1 2019 GlaxoSmithKline PLC Earnings Call TranscriptMay 01, 2019ARS532.5Earnings
Q1 2023 GSK plc Earnings Presentation Transcript
Apr 26, 2023 / 11:00AM GMT
Release Date Price:
ARS4152
(-2.97%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)